Herndon JE - Search Results

1

Quality of life outcomes are equivalent after lobectomy in the elderly.

Burfeind WR Jr, Tong BC, O'Branski E, Herndon JE, Toloza EM, D'Amico TA, Harpole LH, Harpole DH Jr. Burfeind WR Jr, et al. Among authors: herndon je. J Thorac Cardiovasc Surg. 2008 Sep;136(3):597-604. doi: 10.1016/j.jtcvs.2008.02.093. J Thorac Cardiovasc Surg. 2008. PMID: 18805257 Free article.

2

A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers.

D'Amico TA, Massey M, Herndon JE 2nd, Moore MB, Harpole DH Jr. D'Amico TA, et al. Among authors: herndon je 2nd. J Thorac Cardiovasc Surg. 1999 Apr;117(4):736-43. doi: 10.1016/s0022-5223(99)70294-1. J Thorac Cardiovasc Surg. 1999. PMID: 10096969 Free article.

3

Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.

D'Amico TA, Brooks KR, Joshi MB, Conlon D, Herndon J 2nd, Petersen RP, Harpole DH Jr. D'Amico TA, et al. Ann Thorac Surg. 2006 Jun;81(6):1982-7; discussion 1987. doi: 10.1016/j.athoracsur.2006.01.042. Ann Thorac Surg. 2006. PMID: 16731117

4

Video-assisted thoracic surgery lobectomy: report of CALGB 39802--a prospective, multi-institution feasibility study.

Swanson SJ, Herndon JE 2nd, D'Amico TA, Demmy TL, McKenna RJ Jr, Green MR, Sugarbaker DJ. Swanson SJ, et al. Among authors: herndon je 2nd. J Clin Oncol. 2007 Nov 1;25(31):4993-7. doi: 10.1200/JCO.2007.12.6649. J Clin Oncol. 2007. PMID: 17971599 Clinical Trial.

5

Measurement of chemoresistance markers in patients with stage III non-small cell lung cancer: a novel approach for patient selection.

Brooks KR, To K, Joshi MB, Conlon DH, Herndon JE 2nd, D'Amico TA, Harpole DH Jr. Brooks KR, et al. Among authors: herndon je 2nd. Ann Thorac Surg. 2003 Jul;76(1):187-93; discussion 193. doi: 10.1016/s0003-4975(03)00131-0. Ann Thorac Surg. 2003. PMID: 12842538

6

Molecular biologic substaging of stage I lung cancer according to gender and histology.

D'Amico TA, Aloia TA, Moore MB, Herndon JE 2nd, Brooks KR, Lau CL, Harpole DH Jr. D'Amico TA, et al. Among authors: herndon je 2nd. Ann Thorac Surg. 2000 Mar;69(3):882-6. doi: 10.1016/s0003-4975(99)01522-2. Ann Thorac Surg. 2000. PMID: 10750777

7

Predicting the sites of metastases from lung cancer using molecular biologic markers.

D'Amico TA, Aloia TA, Moore MB, Conlon DH, Herndon JE 2nd, Kinch MS, Harpole DH Jr. D'Amico TA, et al. Among authors: herndon je 2nd. Ann Thorac Surg. 2001 Oct;72(4):1144-8. doi: 10.1016/s0003-4975(01)02979-4. Ann Thorac Surg. 2001. PMID: 11603427

8

Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer.

Harpole DH Jr, Richards WG, Herndon JE 2nd, Sugarbaker DJ. Harpole DH Jr, et al. Among authors: herndon je 2nd. Ann Thorac Surg. 1996 May;61(5):1470-6. doi: 10.1016/0003-4975(96)00104-X. Ann Thorac Surg. 1996. PMID: 8633961

9

Localized adenocarcinoma of the lung: oncogene expression of erbB-2 and p53 in 150 patients.

Harpole DH Jr, Marks JR, Richards WG, Herndon JE 2nd, Sugarbaker DJ. Harpole DH Jr, et al. Among authors: herndon je 2nd. Clin Cancer Res. 1995 Jun;1(6):659-64. Clin Cancer Res. 1995. PMID: 9816029

10

Tumor marker expression is predictive of survival in patients with esophageal cancer.

Aloia TA, Harpole DH Jr, Reed CE, Allegra C, Moore MB, Herndon JE 2nd, D'Amico TA. Aloia TA, et al. Among authors: herndon je 2nd. Ann Thorac Surg. 2001 Sep;72(3):859-66. doi: 10.1016/s0003-4975(01)02838-7. Ann Thorac Surg. 2001. PMID: 11565671

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

399 results

Search Page

Filters